articleThe Lancet Infectious DiseasesMar 2, 2016BRONZE OA

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial

EDEvelien de JongJAJos A van OersABAlbertus BeishuizenPVPiet VosWJWytze J. Vermeijden

Amsterdam UMC Location VUmc · Elisabeth-TweeSteden Ziekenhuis · +15 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

821
total citations
FWCI
74.42
Percentile
100%
References
34
Citations per year

Authors

30

Topics & keywords

Topics
Keywords
  • Procalcitonin
  • Medicine
  • Antibiotics
  • Sepsis
  • Discontinuation
  • Intensive care medicine
  • Randomized controlled trial
  • Internal medicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.